SORRENTO THERAPEUTICS INC (SRNE) Net Income by Year
SORRENTO THERAPEUTICS INC reported a net loss of $572.8M in fiscal year 2022. This represents a decrease of 33.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2022 through Q2 FY2023, the same line adds up to a $548.1M net loss. The table below carries 15 fiscal years, from 2008 to 2022, and the quarters SORRENTO THERAPEUTICS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SRNE Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K | FY0810-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$548.1M | -$572.8M-33.7% | -$428.3M-43.5% | -$298.5M-2.2% | -$292.1M-43.5% | -$203.5M-2328.9% | $9.1M+115.0% | -$60.9M-33.0% | -$45.8M-32.2% | -$34.7M-58.2% | -$21.9M-352.2% | -$4.8M-49.7% | -$3.2M-79.0% | -$1.8M-91.9% | -$942K-3523.1% | -$26K |
TTM is the trailing twelve months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
SRNE Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More SORRENTO THERAPEUTICS INC financials
Frequently Asked Questions
What was SORRENTO THERAPEUTICS INC's net income in fiscal year 2022?
SORRENTO THERAPEUTICS INC reported a net loss of $572.8M in fiscal year 2022.
How fast is SORRENTO THERAPEUTICS INC's net income growing?
SORRENTO THERAPEUTICS INC (SRNE) net income fell by 33.7% year over year, from -$428.3M to -$572.8M in fiscal year 2022.
What is SORRENTO THERAPEUTICS INC's net income over the last twelve months?
SORRENTO THERAPEUTICS INC (SRNE) reported a $548.1M net loss over the trailing 12 months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
How has SORRENTO THERAPEUTICS INC's net income changed over the years?
Across the 15 fiscal years this page covers, SORRENTO THERAPEUTICS INC (SRNE) net income went from -$26K in fiscal year 2008 to -$572.8M in fiscal year 2022.
What was SORRENTO THERAPEUTICS INC's net income in the most recent quarter?
SORRENTO THERAPEUTICS INC (SRNE) reported -$95.2M in net income in Q2 2023. This represents an increase of 56.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what SORRENTO THERAPEUTICS INC (SRNE) reported on that line in every period on record.